MGC Diagnostics (MGCD) Reports Q1 Loss of $0.06
Tweet
Share
E-mailGet Alerts MGCD Hot Sheet
Join SI Premium – FREE
MGC Diagnostics (NASDAQ: MGCD) reported Q1 EPS of ($0.06). Revenue for the quarter came in at $8.7 million, versus $0 reported last year.
For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
- Gossamer Bio Inc. (GOSS) Tops Q2 EPS by 4c
- Intellicheck (IDN) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
